Endometriosis Affects 10% of Women Yet Takes 5-12 Years to Diagnose

Endometriosis represents a significant women's health challenge, affecting up to 10% of reproductive-age women globally and 9 million women in the United States. This chronic, estrogen-dependent inflammatory condition occurs when endometrial-like tissue grows outside the uterine lining, creating lesions that cause debilitating symptoms.

This comprehensive JAMA review analyzed current understanding of endometriosis diagnosis and treatment. The condition presents with varying symptoms, but 90% of patients experience pelvic pain including painful periods, chronic pelvic pain, and painful intercourse. Additionally, 26% of women with endometriosis struggle with infertility. Risk factors include early menstruation, shorter menstrual cycles, lower body weight, and never having children.

Despite its prevalence, endometriosis diagnosis remains problematic. Women typically wait 5-12 years for proper diagnosis and consult three or more clinicians before receiving appropriate care. While definitive diagnosis requires surgical visualization, clinical diagnosis can be made through symptoms, physical examination, and imaging studies.

Treatment effectiveness varies significantly. A network meta-analysis of 15 clinical trials involving 1,680 participants showed hormonal treatments reduce pain by 13-17 points on a 100-point scale compared to placebo. However, 11-19% of patients don't respond to hormonal therapy, and 25-34% experience pain recurrence within a year of stopping treatment. Even hysterectomy, considered a last resort, fails in 25% of cases, with 10% requiring additional surgery.

These findings highlight the urgent need for better diagnostic tools and more effective treatments for this common yet under-recognized condition affecting millions of women.